April 8, 2026

Science Chronicle

A Science and Technology Blog

April 8, 2026

Science Chronicle

A Science and Technology Blog

Drug companies

ChildrenCough syrupDiethylene glycol (DEG)Drug safetyFixed-dose combinations

Cough Syrups: How Irrational Fixed-Dose Combinations Can Turn Fatal

Cough syrups containing a mixture of antitussives, antihistamines, decongestants and expectorants may appear logical — one drug to dry secretions, another to suppress cough, a third to open nasal passages. But the underlying flaw is that these ingredients often work in opposing ways or have overlapping side effects

Read More
ChildrenCough syrupDiethylene glycol (DEG)Drug companiesDrug safety

Poison in cough syrup bottles: The never-ending saga of DEG-related deaths

As long as protecting the reputation and interests of the Indian pharmaceutical industry is the top priority, it is unlikely that there will be any meaningful reforms to prevent future tragedies caused by DEG. The bid to cover up, distract and obfuscate, as seen in the last few days, serves as valuable pointers

Read More
Drug safetyFixed dose combination drugsGeneric medicines

Why is irrational use of monteleukast as a combination drug continuing despite serious adverse effects?

Most antihistamines are sold as generics and are inexpensive. On the other hand, irrational combinations with montelukast sell at two-four times the cost of an antihistamine alone. The drug combinations are nothing but a sinister way to profiteer from common conditions. The proof: sales of montelukast as a standalone drug dropped 14%, while sales of combinations increased by 25% in 2023-24, with close to 200 registered brands selling combinations

Read More
Drug companiesDrug safetyDrugsMedicinePharmaceutical companies

Indian pharma products exported to other countries fail the safety test, cause deaths

India can continue to be the pharmacy of the global south only if the regulator begins to behave like a watchdog to ensure drug safety, and not as a facilitator for the pharma industry

Read More
Drug companiesDrug discoveryDrugsHealthWHOWorld Health Organisation

When pills make us worse: Monitoring the adverse effects of medicines

By Debaleena Basu A healthy 21-year-old youth was admitted to a hospital for an elective surgery. All preoperative physiological parameters

Read More
Drug companiesDrug resistancePharmaceutical companies

Drug resistance: The antibiotic red line of control

A much-needed public awareness campaign to highlight the dangers of misuse and irrational use of antibiotics was recently launched by

Read More
ChinaDrug companiesDrugsEditorialICMRPharmaceutical companiesResearch

Editorial: Time for pharma course correction

The Finance Ministry’s decision to withdraw customs duty exemptions for 76 life-saving drugs will at once make them more expensive

Read More
Drug companiesEditorialFake journals

Editorial: Merck publishes a fake journal

The spectre of Vioxx, the blockbuster non-steroidal anti inflammatory drug (NSAID), continues to haunt pharmaceutical giant Merck even five years

Read More
Drug companiesDrugsPharmaceutical companies

Is the doctor-drug industry nexus harming patients?

Published in The Hindu on November 8, 2007 Companies in the U.S. that produce drugs and medical devices with a

Read More
Drug companiesDrugsEditorialPharmaceutical companies

Editorial: Towards greater transparency

Published in The Hindu on November 5, 2007 Pharmaceutical companies and doctors make for uneasy bedfellows.  While the two cannot

Read More
Clinical trialCloningDrug companiesEditorialPharmaceutical companiesStem cells

Editorial: A fine initiative

Published in The Hindu on October 24, 2007 The recent announcement of a public-private partnership by three Europe-based pharmaceutical companies

Read More
CDCDrug companiesDrugsEditorialHIVHIV/AIDSPharmaceutical companiesWHOWorld Health Organisation

Editorial: Expanding access to HIV testing

Published in The Hindu on July 4, 2007 The new guidelines issued recently by the World Health Organisation to expand

Read More
Drug companiesDrugsEditorialPharmaceutical companiesWHOWorld Health Organisation

Editorial: Developing drugs for the poor

Published in The Hindu on March 9, 2007 The World Health Organisation (WHO) has taken some notable steps to address

Read More